Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “SARS”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 469 records · Page 26
All sourcesNASA NTRSDOE OSTI
NASA NTRS2017

Large-scale product of forest height using a new approach from spaceborne repeat-pass SAR interferometry and LIDAR

Spaceborne SAR interferometry (InSAR) has the potential of mapping the forest height on a global scale and a monthly/weekly basis under all weather conditions, which can improve our understanding of the global carbon dynamics. In previous work, repeatpass SAR interferometry from spaceborne sensors is utilized to create large-scale forest height maps (that are particularly interested for large-scale ecological research) based on a newly developed approach. This paper thus serves as a summary paper and also sheds light on the future directions with improved results. In particular, it will be shown that repeat-pass SAR interferometry is able to create a large-scale forest height mosaic product with RMSE 4 m for forest stands on the order of 20 hectares through using the past spaceborne repeat-pass InSAR observations (i.e. JAXA’s ALOS-1 and ALOS-2) combined with sparse airborne lidar training samples over the forested areas in New England, US. Moreover, the results and performance of this approach can be remarkably improved with several enhancement techniques that can be easily satisfied with use of future spaceborne repeat-pass InSAR and lidar missions (e.g. NASA-ISRO’s NISAR and NASA’s GEDI). The methodology described in this paper can be considered as a complimentary tool to the existing PolInSAR technique and also serves as an observing prototype for the future spaceborne missions of repeatpass InSAR in fusion with lidar (e.g. NISAR and GEDI).

Treuhaft, Robert↗
NASA NTRSDate not supplied

A Cloud-Based Operational Surface Water Extent Mapping Service from Sentinel-1 SAR

With its weather independence and day-and-night capabilities, SAR has long been known as a useful data set for flood monitoring. The recently launched Sentinel-1 (S1) C-band sensors, with their regularly acquired, free-and-open data, have finally elevated SAR to a relevant data source in operational hazard response. Leveraging these capabilities of S1, this poster introduces the HYDRO30 product, a 30-m resolution surface water extent product derived from dual-pol S1 SAR data. To enable automatic and near real-time product generation, HYDRO30 is embedded in the HydroSAR service, a cloud-based production pipeline developed by the University of Alaska Fairbanks in collaboration with the NASA Alaska Satellite Facility DAAC and the NASA Marshall and Goddard Space Flight Centers.

Franz J Meyer↗
NASA NTRSDate not supplied

Harmonized Sentinel-1 SAR Global River Geometry and Inundation Database

Satellite-based observations on river geometries are sporadic in time, space, or both. Most satellite-based surface water maps, river widths, water surface elevations (WSE), slopes, and bathymetry are asynchronized in time and space. The current configuration of satellites such as Sentinel-6 measured the WSE but is missing the river width, slopes, and depths. To advance hydrological sciences research, there is a need to produce a harmonized time series of river geometry data of non-SWOT satellites in partnership with the upcoming SWOT mission. The SWOT satellite will measure river width, height, and slope but missing river depth measurements in space and time. Further, none of these current satellites measure the WSE, river width, and slopes synchronously. In this work, we use the Sentinel-1 SAR satellite data archive from 2015 to the present to create a global river width and surface water database at the reach scale. A modified version of the Sentinel SAR surface water classification algorithm from ASF is used to quantify the surface water extent on the stream approximately every six days (at the equator) at 10m spatial resolution globally. This 10m water mask is fed into a workflow to quantify the river widths, surface water inundations, slopes, and synthetic bathymetry in SWORD (SWOT River Database) stream networks. A Satellite HAND is used to address the cloud obscured surface water observations using a trained machine learning algorithm. We use WSE derived from the Global Water Monitor from NASA GSFC, Hydroweb from LEGOS, and ICESat-2 to harmonize the WSE observation. And Landsat-8/9 and Sentinel-2 water observations to fill the gaps in the Sentinel-1 SAR database. We use Congo River Basin as a test case where we have more than 500 radar altimetry-based WSE, continuous series of Sentinel-1, ICESat-2, Landsat-8/9, and Sentinel-2 observations. A Congo River hydrologic model is used to generate the streamflow discharge. The satellite observed river reaches are assimilated with the stream flows computed by the routing models. And the downstream reaches in the river network without satellite observations get optimized for discharge/river geometry at each observation cycle. Our final product is a harmonized river geometry dataset (reach's water extent, WSE, slope, synthetic bathymetry) for Congo Basin's SWORD reaches.

Chandana Gangodagamage↗
NASA NTRSDate not supplied

Evaluating SAR Radiometric Terrain Correction Solutions: Optimal products for applied users

Operational applications of Synthetic Aperture Radar (SAR) are under development around the world, driven by the regularly-acquired, free-and-open source C-band SAR observations provided by ESA’s Sentinel-1 sensor constellation since 2014. Groups like SERVIR, a joint NASA and USAID initiative, are at the forefront of remote sensing applications for societal benefit. A takeaway from SERVIR’s experience is the need for appropriately geocoded and fully calibrated SAR data that is ready to use for a range of ecosystems-related applications. Radiometric Terrain Corrected (RTC) data are key entry-level products for multiple applications that range from ecosystems to hazards. This work fills a gap in current research by evaluating several RTCs produced by open-source software solutions (SNAP-7 and ISCE-2), the gold standard commercial software (GAMMA), a Google Earth Engine (GEE) based workflow, and the uncorrected GRD products currently available in GEE. RTCs were analyzed for geolocation quality, absolute radiometric calibration, and fidelity of the radiometric terrain flattening over ten sites representing varied terrains. In addition, a time series analysis was conducted over two locations. Overall, no significant differences for radiometric calibration were found across RTC products. However, all RTCs performed better than uncorrected GRD products. The main differences between products were found in geolocation quality. These results not only demonstrate the need for the uptake and distribution of RTC products for ecosystems applications, but demonstrate the ability to do so with open source methods, adding value to developing affordable operational applications.

Helen Blue Parache↗
DOE OSTI2024

SARS-CoV-2 variant nanobodies and constructs comprising such nanobodies

A large and highly diverse nanobody library was constructed and screened against multiple variants of SARS-COV-2 to find nanobodies with high sensitivity and specificity for the variants. Four rounds of positive selection against a panel of six diverse SARS-COV-2 variant RBDs was performed with our high-diversity. At least 59 of these nanobodies were found to work well against Alpha, Beta, Gamma, Delta, Kappa, Lambda and Mu with some overlap efficacy against other variants. These nanobodies have efficacy as stand-alone nanobodies and as a construct comprising nanobodies linked to the human IgG1 constant fragment (Fc) (nanobody-hFc constructions or nb-hFcs) to make enhanced humanized sdAbs with all the attributes of nanobodies with improved half-life and optimized effector functions. Several promising nanobodies that neutralize the original SARS-COV-2 and several of its variants have been identified, including Delta, with high efficacy. In particular, a subset of these nanobodies bind to the Omicron RBD.

Harmon, Brooke Nicole↗
NASA NTRS2003

The use of polarimetric and interferometric SAR data in floodplain mapping

Recent advances in polarimetric SAR show promise for augmenting the capability of traditional interferometric SAR. In particular, a polarimetric topography technique provides useful slope information, and polarimetric interferometry may be used to decompose the response into vegetation and ground surface contributions.

polarimetric SAR interferometric SAR↗
NASA NTRS2013

Forest Structure Characterization Using JPL's UAVSAR Multi-Baseline Polarimetric SAR Interferometry and Tomography

This paper concerns forest remote sensing using JPL's multi-baseline polarimetric interferometric UAVSAR data. It presents exemplary results and analyzes the possibilities and limitations of using SAR Tomography and Polarimetric SAR Interferometry (PolInSAR) techniques for the estimation of forest structure. Performance and error indicators for the applicability and reliability of the used multi-baseline (MB) multi-temporal (MT) PolInSAR random volume over ground (RVoG) model are discussed. Experimental results are presented based on JPL's L-band repeat-pass polarimetric interferometric UAVSAR data over temperate and tropical forest biomes in the Harvard Forest, Massachusetts, and in the La Amistad Park, Panama and Costa Rica. The results are partially compared with ground field measurements and with air-borne LVIS lidar data.

UAVSAR (Uninhabited Aerial Vehicle SAR)↗
DOE OSTI2020

Mechanistic modelling of SARS-CoV-2 and other infectious diseases and the effects of therapeutics

Modern viral kinetic modeling and its application to therapeutics is a field that attracted the attention of the medical, pharmaceutical and modeling communities during the early days of the AIDS epidemic. Its successes lead to applications of modeling methods not only to HIV but a plethora of other viruses, such as hepatitis C virus (HCV), hepatitis B virus (HBV) and cytomegalovirus (CMV), which along with HIV cause chronic diseases, and viruses such as influenza, respiratory syncytial virus (RSV), West Nile virus (WNV), Zika virus, and SAR-CoV-2, which generally cause acute infections. Here we first review the historical development of mathematical models to understand HIV and HCV infections and the effects of treatment by fitting the models to clinical data. Furthermore, we then focus on recent efforts and contributions of applying these models towards understanding SARS-CoV-2 infection and highlight outstanding questions where modeling can provide crucial insights and help to optimize non-pharmaceutical and pharmaceutical interventions of the COVID-19 pandemic. The review is written from our personal perspective emphasizing the power of simple target cell limited models that provided important insights and then their evolution into more complex models that captured more of the virology and immunology. To quote Albert Einstein “Everything should be made as simple as possible, but not simpler”, and this idea underlies the modeling we describe below.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2021

Evolution of the SARS-CoV -2 proteome in three dimensions (3D) during the first 6 months of the COVID -19 pandemic

Understanding the molecular evolution of the SARS-CoV-2 virus as it continues to spread in communities around the globe is important for mitigation and future pandemic preparedness. Three-dimensional structures of SARS-CoV-2 proteins and those of other coronavirusess archived in the Protein Data Bank were used to analyze viral proteome evolution during the first 6 months of the COVID-19 pandemic. Analyses of spatial locations, chemical properties, and structural and energetic impacts of the observed amino acid changes in >48 000 viral isolates revealed how each one of 29 viral proteins have undergone amino acid changes. Catalytic residues in active sites and binding residues in protein–protein interfaces showed modest, but significant, numbers of substitutions, highlighting the mutational robustness of the viral proteome. Energetics calculations showed that the impact of substitutions on the thermodynamic stability of the proteome follows a universal bi-Gaussian distribution. Here detailed results are presented for potential drug discovery targets and the four structural proteins that comprise the virion, highlighting substitutions with the potential to impact protein structure, enzyme activity, and protein–protein and protein–nucleic acid interfaces. Characterizing the evolution of the virus in three dimensions provides testable insights into viral protein function and should aid in structure-based drug discovery efforts as well as the prospective identification of amino acid substitutions with potential for drug resistance.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2021

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

All current vaccines for COVID-19 utilize ancestral SARS-CoV-2 spike with the goal of generating protective neutralizing antibodies. The recent emergence and rapid spread of several SARS-CoV-2 variants carrying multiple spike mutations raise concerns about possible immune escape. One variant, first identified in the United Kingdom (B.1.1.7, also called 20I/501Y.V1), contains eight spike mutations with potential to impact antibody therapy, vaccine efficacy, and risk of reinfection. Here in this paper, we show that B.1.1.7 remains sensitive to neutralization, albeit at moderately reduced levels (~2-fold), by serum samples from convalescent individuals and recipients of an mRNA vaccine (mRNA-1273, Moderna) and a protein nanoparticle vaccine (NVX-CoV2373, Novavax). A subset of monoclonal antibodies to the receptor binding domain (RBD) of spike are less effective against the variant, while others are largely unaffected. Lastly, these findings indicate that variant B.1.1.7 is unlikely to be a major concern for current vaccines or for an increased risk of reinfection.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2022

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

As an essential enzyme of SARS-CoV-2, the COVID-19 pathogen, main protease (M Pro ) is a viable target to develop antivirals for the treatment of COVID-19. By varying chemical compositions at both P2 and P3 positions and the N-terminal protection group, we synthesized 18 tripeptidyl M Pro inhibitors that contained also an aldehyde warhead and β-(S-2-oxopyrrolidin-3-yl)-alaninal at the P1 position. Systematic characterizations of these inhibitors were conducted, including their in vitro enzymatic inhibition potency, X-ray crystal structures of their complexes with M Pro , their inhibition of M Pro transiently expressed in 293T cells, and cellular toxicity and SARS-CoV-2 antiviral potency of selected inhibitors. These inhibitors have a large variation of determined in vitro enzymatic inhibition IC 50 values that range from 4.8 to 650 nM. Here, the determined in vitro enzymatic inhibition IC 50 values reveal that relatively small side chains at both P2 and P3 positions are favorable for achieving high in vitro M Pro inhibition potency, the P3 position is tolerable toward unnatural amino acids with two alkyl substituents on the α-carbon, and the inhibition potency is sensitive toward the N-terminal protection group. X-ray crystal structures of M Pro bound with 16 inhibitors were determined. In all structures, the M Pro active site cysteine interacts covalently with the aldehyde warhead of the bound inhibitor to form a hemithioacetal that takes an S configuration. For all inhibitors, election density around the N-terminal protection group is weak indicating possible flexible binding of this group to M Pro . In M Pro , large structural variations were observed on residues N142 and Q189. Unlike their high in vitro enzymatic inhibition potency, most inhibitors showed low potency to inhibit M Pro that was transiently expressed in 293T cells. Inhibitors that showed high potency to inhibit M Pro transiently expressed in 293T cells all contain O-tert-butyl-threonine at the P3 position. These inhibitors also exhibited relatively low cytotoxicity and high antiviral potency. Overall, our current and previous studies indicate that O-tert-butyl-threonine at the P3 site is a key component to achieve high cellular and antiviral potency for tripeptidyl aldehyde inhibitors of M Pro .

60 APPLIED LIFE SCIENCES↗
DOE OSTI2022

Molecular insights into the differential dynamics of SARS-CoV-2 variants of concern

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected the lives and livelihood of millions of individuals around the world. It has mutated several times after its first inception, with an estimated two mutations occurring every month. Although we have been successful in developing vaccines against the virus, the emergence of variants has enabled it to escape therapy. Few of the generated variants are also reported to be more infectious than the wild-type (WT). In this study, we analyze the attributes of all RBD/ACE2 complexes for the reported VOCs, namely, Alpha, Beta, Gamma, and Delta through computer simulations. Results indicate differences in orientation and binding energies of the VOCs from the WT. Overall, it was observed that electrostatic interactions play a major role in the binding of the complexes. Detailed residue level energetics revealed that the most prominent changes in interaction energies were seen particularly at the mutated residues which were present at RBD/ACE2 interface. We found that the Delta variant is one of the most tightly bound variants of SARS-CoV-2 with dynamics similar to WT. The high binding affinity of RBD towards ACE2 is indicative of an increase in viral transmission and infectivity. The details presented in our study provide additional information for the design and development of effective therapeutic strategies for the emerging variants of the virus in the future.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2021

Near-physiological-temperature serial crystallography reveals conformations of SARS-CoV-2 main protease active site for improved drug repurposing

The COVID-19 pandemic has resulted in 198 million reported infections and more than 4 million deaths as of July 2021 (covid19.who.int). Research to identify effective therapies for COVID-19 includes: (1) designing a vaccine as future protection; (2) de novo drug discovery; and (3) identifying existing drugs to repurpose them as effective and immediate treatments. To assist in drug repurposing and design, we determine two apo structures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease at ambient temperature by serial femtosecond X-ray crystallography. We employ detailed molecular simulations of selected known main protease inhibitors with the structures and compare binding modes and energies. The combined structural and molecular modeling studies not only reveal the dynamics of small molecules targeting the main protease but also provide invaluable opportunities for drug repurposing and structure-based drug design strategies against SARS-CoV-2.

59 BASIC BIOLOGICAL SCIENCES↗
DOE OSTI2022

Remote Floating-Gate Field-Effect Transistor with 2-Dimensional Reduced Graphene Oxide Sensing Layer for Reliable Detection of SARS-CoV-2 Spike Proteins

Despite intensive research of nanomaterials-based field-effect transistors (FETs) as a rapid diagnostic tool, it remains to be seen for FET sensors to be used for clinical applications due to a lack of stability, reliability, reproducibility, and scalability for mass production. In this work, we propose a remote floating-gate (RFG) FET configuration to eliminate device-to-device variations of two-dimensional reduced graphene oxide (rGO) sensing surfaces and most of the instability at the solution interface. Also, critical mechanistic factors behind the electrochemical instability of rGO such as severe drift and hysteresis were identified through extensive studies on rGO–solution interfaces varied by rGO thickness, coverage, and reduction temperature. rGO surfaces in our RFGFET structure displayed a Nernstian response of 54 mV/pH (from pH 2 to 11) with a 90% yield (9 samples out of total 10), coefficient of variation (CV) < 3%, and a low drift rate of 2%, all of which were calculated from the absolute measurement values. As proof-of-concept, we demonstrated highly reliable, reproducible, and label-free detection of spike proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a saliva-relevant media with concentrations ranging from 500 fg/mL to 5 μg/mL, with an R 2 value of 0.984 and CV < 3%, and a guaranteed limit of detection at a few pg/mL. Taken together, this new platform may have an immense effect on positioning FET bioelectronics in a clinical setting for detecting SARS-CoV-2.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗
DOE OSTI2023

SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals

The main protease of SARS-CoV-2 (M pro ) is the most promising drug target against coronaviruses due to its essential role in virus replication. With newly emerging variants there is a concern that mutations in M pro may alter the structural and functional properties of protease and subsequently the potency of existing and potential antivirals. We explored the effect of 31 mutations belonging to 5 variants of concern (VOCs) on catalytic parameters and substrate specificity, which revealed changes in substrate binding and the rate of cleavage of a viral peptide. Crystal structures of 11 M pro mutants provided structural insight into their altered functionality. Additionally, we show M pro mutations influence proteolysis of an immunomodulatory host protein Galectin-8 (Gal-8) and a subsequent significant decrease in cytokine secretion, providing evidence for alterations in the escape of host-antiviral mechanisms. Accordingly, mutations associated with the Gamma VOC and highly virulent Delta VOC resulted in a significant increase in Gal-8 cleavage. Importantly, IC50s of nirmatrelvir (Pfizer) and our irreversible inhibitor AVI-8053 demonstrated no changes in potency for both drugs for all mutants, suggesting M pro will remain a high-priority antiviral drug candidate as SARS-CoV-2 evolves.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗
DOE OSTI2022

Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor

Inhibition of the SARS-CoV-2 main protease (M pro ) is a major focus of drug discovery efforts against COVID-19. Here we report a hit expansion of non-covalent inhibitors of M pro . Starting from a recently discovered scaffold (The COVID Moonshot Consortium. Open Science Discovery of Oral Non-Covalent SARS-CoV-2 Main Protease Inhibitor Therapeutics. bioRxiv 2020.10.29.339317) represented by an isoquinoline series, we searched a database of over a billion compounds using a cheminformatics molecular fingerprinting approach. We identified and tested 48 compounds in enzyme inhibition assays, of which 21 exhibited inhibitory activity above 50% at 20 μM. Among these, four compounds with IC 50 values around 1 μM were found. Interestingly, despite the large search space, the isoquinolone motif was conserved in each of these four strongest binders. Room-temperature X-ray structures of co-crystallized protein–inhibitor complexes were determined up to 1.9 Å resolution for two of these compounds as well as one of the stronger inhibitors in the original isoquinoline series, revealing essential interactions with the binding site and water molecules. Molecular dynamics simulations and quantum chemical calculations further elucidate the binding interactions as well as electrostatic effects on ligand binding. The results help explain the strength of this new non-covalent scaffold for M pro inhibition and inform lead optimization efforts for this series, while demonstrating the effectiveness of a high-throughput computational approach to expanding a pharmacophore library.

60 APPLIED LIFE SCIENCES↗
DOE OSTI2026

Nicotine-Inspired, De Novo-Designed SARS-CoV-2 Main Protease Inhibitors Reveal Unique Chemistry for Covalently Conjugating Both Cysteine and Histidine Residues in the Catalytic Dyad

Anecdotal reports about smokers with low SARS-CoV-2 infection rates prompted a search for nicotine and its pyrolysis products as SARS-CoV-2 main protease (M Pro ) inhibitors. From this search, 3-vinylpyridine was discovered as a weak binder for the M Pro S1 subsite and was used subsequently as a de novo starting point for covalent inhibitor design that quickly yielded a highly potent inhibitor, SR-A-174, with an IC 50 value of 60 nM. Representing a novel class of M Pro inhibitors, SR-A-174 features an N,N -diaryl-α,α-dichloroacetamide scaffold that facilitated rapid exploration of alternative covalent warheads and various N-substituents, leading to the identification of multiple inhibitors with potent antiviral activity. Eight such M Pro inhibitor structures were determined, all demonstrating covalent binding to catalytic Cys145 of M Pro . In six determined structures, binding is dominated by the covalent bond plus van der Waals contacts, which contrasts with the extensive hydrogen bond networks formed with peptidomimetic inhibitors such as nirmatrelvir. Strikingly, two N,N -diaryl-α,α-dichloroacetamide inhibitors exhibit an unprecedented dual covalent modification mode of the catalytic dyad, forming bonds to both Cys145 and His41 with a concomitant loss of both chlorides and displacing the inhibitors from the S1 subsite. This dyad-targeting reactivity suggests a novel route for bioconjugation of both cysteine and histidine.

SARS-CoV-2↗